Aspira Women's Health Files 8-K
Ticker: AWHL · Form: 8-K · Filed: Oct 23, 2024 · CIK: 926617
| Field | Detail |
|---|---|
| Company | Aspira Women'S Health INC. (AWHL) |
| Form Type | 8-K |
| Filed Date | Oct 23, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $10 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, company-information
TL;DR
Aspira Women's Health filed an 8-K on 10/23/24. Standard disclosure.
AI Summary
Aspira Women's Health Inc. filed an 8-K on October 23, 2024, reporting other events and financial statements. The company, formerly known as Vermillion, Inc., Ciphergen Biosystems Inc., and Abiotic Systems, is incorporated in Delaware and headquartered in Austin, Texas.
Why It Matters
This filing indicates that Aspira Women's Health Inc. has made official disclosures regarding company events and financial information to the SEC.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports significant events or financial updates, but the content itself doesn't indicate immediate high risk.
Key Numbers
- 001-34810 — SEC File Number (Identifies the company's filing with the SEC.)
- 33-0595156 — IRS Employer Identification No (Company's tax identification number.)
Key Players & Entities
- Aspira Women's Health Inc. (company) — Registrant
- October 23, 2024 (date) — Date of earliest event reported
- Vermillion, Inc. (company) — Former company name
- Ciphergen Biosystems Inc (company) — Former company name
- Abiotic Systems (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Austin, Texas (location) — Business address city and state
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The provided text is a header and does not detail the specific 'Other Events' being reported, only that this item is included.
What is the primary business of Aspira Women's Health Inc.?
Aspira Women's Health Inc. is in the business of 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES' as indicated by its Standard Industrial Classification code.
When did Aspira Women's Health Inc. change its name from Vermillion, Inc.?
The filing indicates the name change from Vermillion, Inc. occurred on August 24, 2007.
What is the fiscal year end for Aspira Women's Health Inc.?
The fiscal year end for Aspira Women's Health Inc. is December 31st.
What is the physical address of Aspira Women's Health Inc.?
The business address is 12117 Bee Caves Road, Building Three, Suite 100, Austin, TX 78738.
Filing Stats: 457 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-10-23 13:29:26
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share AWH The Nasdaq Stock Mark
- $10 million — omen's Health. The Company will receive $10 million in funding over two years through the S
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex99-1.htm (EX-99.1) — 16KB
- 0001493152-24-042202.txt ( ) — 232KB
- awh-20241023.xsd (EX-101.SCH) — 3KB
- awh-20241023_lab.xml (EX-101.LAB) — 33KB
- awh-20241023_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Aspira Women's Health Inc. Date: October 23, 2024 By: /s/ Nicole Sandford Nicole Sandford, Chief Executive Officer